enhancer

Chromatin State Dynamics Confers Specific Therapeutic Strategies in Enhancer Subtypes of Colorectal Cancer

Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state

Enhancer reprogramming confers dependence on glycolysis and IGF signaling in KMT2D mutant melanoma